p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions

被引:0
作者
Ajiki, T [1 ]
Onoyama, H [1 ]
Yamamoto, M [1 ]
Asaka, K [1 ]
Fujimori, T [1 ]
Maeda, S [1 ]
Saitoh, Y [1 ]
机构
[1] KOBE UNIV,SCH MED,DEPT PATHOL 2,KOBE 650,JAPAN
关键词
p53; gallbladder cancer; prognosis; DNA ploidy pattern; dysplasia;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: p53 protein expression in gallbladder carcinoma has recently been detected by immunohistochemical techniques, but the relationship between p53 expression and prognosis or clinicopathological factors is still obscure. Materials and Methods: We investigated 48 gallbladder carcinoma, 7 adenoma and 11 dysplasia cases for p53 expression by immunohistochemical techniques. Results: p53 expression was positive in 39.6% of gallbladder cancer cases, but in no adenoma or dysplasia cases. No significant correlation, was found between p53 overexpression and prognosis or recurrence in 20 patients with carcinoma involvement up to the sub-serosal layer. p53 overexpression was correlated with DNA aneuploidy pattern and the absence of stones, but teas not correlated with clinical staging or lymph node metastasis. Conclusion: These results suggest that p53 gene mutation is related to the transition from premalignancy to malignancy in gallbladder carcinogenesis, as well as DNA ploidy alterations and carcinogenesis unassociated with gallstones, but has no bearing on the prognosis.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 28 条
[1]  
ALBORESSAAVEDRA J, 1984, ATLAS TUMOUR PATHOL, P28
[2]  
BARTEK J, 1990, ONCOGENE, V5, P893
[3]  
DOWLING GP, 1986, CANCER, V58, P1702, DOI 10.1002/1097-0142(19861015)58:8<1702::AID-CNCR2820580821>3.0.CO
[4]  
2-Z
[5]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327
[6]   METHOD FOR ANALYSIS OF CELLULAR DNA CONTENT OF PARAFFIN-EMBEDDED PATHOLOGICAL MATERIAL USING FLOW-CYTOMETRY [J].
HEDLEY, DW ;
FRIEDLANDER, ML ;
TAYLOR, IW ;
RUGG, CA ;
MUSGROVE, EA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (11) :1333-1335
[7]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[8]  
KAKLAMANIS L, 1993, AM J PATHOL, V142, P87
[9]   P53 AND C-ERBB-2 PROTEIN EXPRESSION IN ADENOCARCINOMAS AND EPITHELIAL DYSPLASIAS OF THE GALL-BLADDER [J].
KAMEL, D ;
PAAKKO, P ;
NUORVA, K ;
VAHAKANGAS, K ;
SOINI, Y .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :67-72
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481